Aim Rule 26
The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies. CRISM Therapeutics Corporation is incorporated in British Virgin Islands (Registration Number 1010359 ). The Company’s principal country of operation is the UK.
The Company’s ISIN is VGG042401262 and its SEDOL is BS60QF6.
INFORMATION
DETAILS
Description of the business
Directors Biographies
Board Responsibilities
Articles of association
Admission Document
Exchange Details
The Company’s shares trade on AIM, a market operated by the London Stock Exchange.
Issued Share Capital
Financial Reports
Notices
Key Advisers
Details on UK City Code on Takeovers and Mergers
Not applicable as the Company is registered in the British Virgin Islands
Rule 26 Statement
The above information is disclosed in accordance with Rule 26 of the AIM Rules and was last updated on 31 May 2024